Variant report
Variant | nsv964025 |
---|---|
Chromosome Location | chr4:3535969-3544867 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:63)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr4:3538736-3538904 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr4:3536561-3536627 | Kidney_OC | kidney: | n/a | n/a |
3 | CTCF | chr4:3542526-3542604 | GM10266 | blood: | n/a | n/a |
4 | CTCF | chr4:3543557-3543614 | Lung_OC | lung: | n/a | n/a |
5 | CTCF | chr4:3543428-3543512 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr4:3537323-3537378 | GM13976 | blood: | n/a | n/a |
7 | EP300 | chr4:3538783-3538963 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr4:3538610-3539081 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr4:3543980-3544761 | GM12878 | blood: | n/a | n/a |
10 | FOSL2 | chr4:3538691-3539178 | HepG2 | liver: | n/a | chr4:3539054-3539065 |
11 | FOSL2 | chr4:3538727-3539036 | HepG2 | liver: | n/a | n/a |
12 | GABPA | chr4:3538749-3538863 | Hela-S3 | cervix: | n/a | n/a |
13 | GABPA | chr4:3544049-3544782 | Hela-S3 | cervix: | n/a | n/a |
14 | GABPA | chr4:3538691-3539052 | Hela-S3 | cervix: | n/a | n/a |
15 | GATA2 | chr4:3542389-3542660 | K562 | blood: | n/a | n/a |
16 | HEY1 | chr4:3538759-3539035 | K562 | blood: | n/a | n/a |
17 | IRF4 | chr4:3543918-3544829 | GM12878 | blood: | n/a | n/a |
18 | IRF4 | chr4:3538696-3539081 | GM12878 | blood: | n/a | n/a |
19 | IRF4 | chr4:3538765-3539092 | GM12878 | blood: | n/a | n/a |
20 | JUND | chr4:3538790-3538983 | HepG2 | liver: | n/a | n/a |
21 | JUND | chr4:3538804-3538941 | HepG2 | liver: | n/a | n/a |
22 | KAP1 | chr4:3539310-3539502 | U2OS | brain: | n/a | n/a |
23 | KAP1 | chr4:3539476-3539488 | HEK293 | kidney: | n/a | n/a |
24 | NR2F2 | chr4:3539562-3539983 | K562 | blood: | n/a | n/a |
25 | NR2F2 | chr4:3542336-3542649 | K562 | blood: | n/a | n/a |
26 | NR2F2 | chr4:3539535-3539992 | K562 | blood: | n/a | n/a |
27 | PAX5 | chr4:3541149-3541472 | GM12878 | blood: | n/a | n/a |
28 | PAX5 | chr4:3542474-3543205 | GM12878 | blood: | n/a | n/a |
29 | PAX5 | chr4:3541197-3541406 | GM12878 | blood: | n/a | n/a |
30 | PAX5 | chr4:3537677-3537904 | GM12878 | blood: | n/a | n/a |
31 | PAX5 | chr4:3543928-3545116 | GM12878 | blood: | n/a | n/a |
32 | PAX5 | chr4:3543975-3544795 | GM12878 | blood: | n/a | n/a |
33 | PAX5 | chr4:3543880-3544777 | GM12878 | blood: | n/a | n/a |
34 | PAX5 | chr4:3538693-3539069 | GM12878 | blood: | n/a | n/a |
35 | PAX5 | chr4:3538789-3539148 | GM12878 | blood: | n/a | n/a |
36 | POLR2A | chr4:3543227-3543587 | GM12878 | blood: | n/a | n/a |
37 | POLR2A | chr4:3538768-3538974 | Hela-S3 | cervix: | n/a | n/a |
38 | POU2F2 | chr4:3538665-3539194 | GM12878 | blood: | n/a | n/a |
39 | POU2F2 | chr4:3542917-3543484 | GM12878 | blood: | n/a | n/a |
40 | POU2F2 | chr4:3544003-3544815 | GM12878 | blood: | n/a | n/a |
41 | RXRA | chr4:3542764-3543116 | HepG2 | liver: | n/a | n/a |
42 | SETDB1 | chr4:3539295-3539510 | U2OS | brain: | n/a | n/a |
43 | SIN3AK20 | chr4:3538845-3538960 | HepG2 | liver: | n/a | n/a |
44 | SIN3AK20 | chr4:3543922-3544049 | HepG2 | liver: | n/a | n/a |
45 | SIN3AK20 | chr4:3544062-3544725 | HepG2 | liver: | n/a | n/a |
46 | SIX5 | chr4:3538732-3539225 | K562 | blood: | n/a | n/a |
47 | SIX5 | chr4:3538840-3539151 | GM12878 | blood: | n/a | n/a |
48 | SIX5 | chr4:3542875-3543136 | K562 | blood: | n/a | n/a |
49 | SP1 | chr4:3544517-3544785 | GM12878 | blood: | n/a | n/a |
50 | SP1 | chr4:3538674-3538940 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:3536906-3536956 | Caco-2 | colon: | n/a |
2 | chr4:3536906-3536956 | HCM | heart: | n/a |
3 | chr4:3536906-3536956 | HCT-116 | colon: | n/a |
4 | chr4:3536906-3536956 | HAEpiC | amniotic membrane: | n/a |
5 | chr4:3536906-3536956 | MCF-7 | breast: | n/a |
6 | chr4:3536906-3536956 | PANC-1 | pancreas: | n/a |
7 | chr4:3536906-3536956 | HPAEpiC | pulmonary alveolar: | n/a |
8 | chr4:3536906-3536956 | HL-60 | blood: | n/a |
9 | chr4:3536906-3536956 | Hela-S3 | cervix: | n/a |
10 | chr4:3536906-3536956 | Hepatocyte | liver: | n/a |
11 | chr4:3536906-3536956 | HCF | heart: | n/a |
12 | chr4:3536906-3536956 | AG04449 | skin: | fetal |
13 | chr4:3536906-3536956 | GM12891 | blood: | n/a |
14 | chr4:3536906-3536956 | HRPEpiC | eye: | n/a |
15 | chr4:3536906-3536956 | NHDF-neo | bronchial: | n/a |
16 | chr4:3536906-3536956 | HIPEpiC | eye: | n/a |
17 | chr4:3536906-3536956 | T-47D | breast: | n/a |
18 | chr4:3536906-3536956 | NH-A | brain: | n/a |
19 | chr4:3536906-3536956 | K562 | blood: | n/a |
20 | chr4:3536906-3536956 | RPTEC | kidney: | n/a |
21 | chr4:3536906-3536956 | CMK | blood: | n/a |
22 | chr4:3536906-3536956 | HEEpiC | esophagus: | n/a |
23 | chr4:3536906-3536956 | AG04450 | lung: | fetal |
24 | chr4:3536906-3536956 | AG09309 | skin: | n/a |
25 | chr4:3536906-3536956 | PrEC | prostate: | n/a |
26 | chr4:3536906-3536956 | GM06990 | blood: | n/a |
27 | chr4:3536906-3536956 | HMEC | breast: | n/a |
28 | chr4:3536906-3536956 | LNCaP | prostate: | n/a |
29 | chr4:3536906-3536956 | ECC-1 | luminal epithelium: | n/a |
30 | chr4:3536906-3536956 | HNPCEpiC | eye: | n/a |
31 | chr4:3536906-3536956 | GM19239 | blood: | n/a |
32 | chr4:3536906-3536956 | HUVEC | blood vessel: | n/a |
33 | chr4:3536906-3536956 | GM12878 | blood: | n/a |
34 | chr4:3536906-3536956 | SK-N-SH | brain: | n/a |
35 | chr4:3536906-3536956 | NB4 | blood: | n/a |
36 | chr4:3536906-3536956 | ovcar-3 | ovarian: | n/a |
37 | chr4:3536906-3536956 | MCF10A-Er-Src | breast: | n/a |
38 | chr4:3536906-3536956 | GM12892 | blood: | n/a |
39 | chr4:3536906-3536956 | U87 | brain: | n/a |
40 | chr4:3536906-3536956 | NHBE | bronchial: | n/a |
41 | chr4:3536906-3536956 | Jurkat | blood: | n/a |
42 | chr4:3536906-3536956 | SAEC | small airway: | n/a |
43 | chr4:3536906-3536956 | NT2-D1 | testis: | n/a |
44 | chr4:3536906-3536956 | SKMC | muscle: | n/a |
45 | chr4:3536906-3536956 | H1-hESC | embryonic stem cell: | embryo |
46 | chr4:3536906-3536956 | AG10803 | skin: | n/a |
47 | chr4:3536906-3536956 | PFSK-1 | brain: | n/a |
48 | chr4:3536906-3536956 | BE2_C | brain: | n/a |
49 | chr4:3536906-3536956 | BJ | skin: | n/a |
50 | chr4:3536906-3536956 | SK-N-SH_RA | brain: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LRPAP1 | TF binding region |
ENSG00000270090 | TF binding region |
LRPAP1 | CpG island |
ENSG00000270090 | CpG island |
ENSG00000163956 | chromatin interactions |
ENSG00000175920 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189133058 | chr4:3535994-3535995 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs193299792 | chr4:3535997-3535998 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs7672287 | chr4:3536002-3536003 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs558964897 | chr4:3536029-3536030 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs528071656 | chr4:3536034-3536035 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs368838714 | chr4:3536070-3536071 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs563931147 | chr4:3536095-3536096 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2073502 | chr4:3536112-3536113 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs544263291 | chr4:3536118-3536119 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs151134666 | chr4:3536146-3536147 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs531024789 | chr4:3536161-3536162 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs185471753 | chr4:3536162-3536163 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs2073503 | chr4:3536176-3536177 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs536906747 | chr4:3536180-3536181 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs200994626 | chr4:3536193-3536194 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs566902014 | chr4:3536240-3536241 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs539022969 | chr4:3536253-3536254 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs367708522 | chr4:3536265-3536266 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs1794431 | chr4:3536329-3536330 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs10937932 | chr4:3536505-3536506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189209774 | chr4:3536506-3536507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374980323 | chr4:3536514-3536515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369180359 | chr4:3536531-3536532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573746539 | chr4:3536538-3536539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181654264 | chr4:3536564-3536565 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559199685 | chr4:3536573-3536574 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs572539456 | chr4:3536574-3536575 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs62272719 | chr4:3536575-3536576 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs564658160 | chr4:3536576-3536577 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs3108671 | chr4:3536588-3536589 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs530579413 | chr4:3536629-3536630 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs550901662 | chr4:3536635-3536636 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs561567910 | chr4:3536637-3536638 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs530213909 | chr4:3536693-3536694 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs185990343 | chr4:3536707-3536708 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs149890013 | chr4:3536723-3536724 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs59393260 | chr4:3536732-3536733 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs201400261 | chr4:3536823-3536824 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs375154543 | chr4:3536829-3536830 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs199610860 | chr4:3536830-3536831 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs552559078 | chr4:3536844-3536845 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs11736573 | chr4:3536882-3536883 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs76961379 | chr4:3536889-3536890 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs149593055 | chr4:3536895-3536896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181126540 | chr4:3536942-3536943 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs373940515 | chr4:3536962-3536963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144876544 | chr4:3537000-3537001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186261495 | chr4:3537040-3537041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376896377 | chr4:3537053-3537054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190685700 | chr4:3537054-3537055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Ependymoma | 20639864 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3535000-3536000 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
2 | chr4:3535000-3536800 | Weak transcription | Lung | lung |
3 | chr4:3535400-3536000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr4:3535400-3537000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr4:3537000-3537200 | Enhancers | Lung | lung |
6 | chr4:3537000-3537400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |